ARUNAYA vs ARVEE: Stock Comparison
ARVEE LABORATORIES I is the larger company by market capitalisation. ARUNAYA shows a higher ROE, while ARVEE LABORATORIES I shows faster revenue growth, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ARUNAYA leads 2; ARVEE leads 8 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ARUNAYA | ARVEE |
|---|---|---|
| Sector | — | Chemicals |
| Industry | — | Specialty Chemicals |
Price
| Metric | ARUNAYA | ARVEE |
|---|---|---|
| Live Price | — | ₹208.87 |
| Day Change | — | 20% |
| Volume | — | 58,712 |
| 52-Week High | — | ₹290.78 |
| 52-Week Low | — | ₹129.11 |
| Distance from 52W High | — | -28.17% |
Valuation
| Metric | ARUNAYA | ARVEE |
|---|---|---|
| Market Cap | ₹25 Cr | ₹226 Cr |
| P/E Ratio | — | 69.87x |
| P/B Ratio | — | 5.22x |
| EPS | ₹2.12 | ₹3.67 |
| Book Value | ₹27.75 | ₹30.53 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ARUNAYA | ARVEE |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 67.5% |
| EPS Growth (TTM YoY) | 0% | 684.4% |
| Qtr Sales Growth | 89.96% | 59.43% |
| Qtr Profit Growth | 93.15% | 225.68% |
Profitability & Leverage
| Metric | ARUNAYA | ARVEE |
|---|---|---|
| ROE | 7.64% | 7.48% |
| ROCE | 7.68% | 7.73% |
| Net Margin | 0% | 7.65% |
| Operating Margin | 7.51% | 8.46% |
| Debt to Equity | 0.44x | 0.03x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | ARUNAYA | ARVEE |
|---|---|---|
| Promoter Holding | 60.79% | 73.5% |
| FII Holding | — | 0% |
| DII Holding | — | 0% |
| Public Holding | 39.21% | 26.5% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ARUNAYA and ARVEE LABORATORIES I.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.